mercredi 11 mai 2016

Onco Actu du 11 mai 2016

1. Biologie

Research discovers mechanism that causes cancer cells to escape from the immune system [Texas A&M Health Science Center]

New research gives deeper understanding of why some breast cancers are hard to treat [Cancer Research UK]

3.1 Tabac

FDA’s Final Deeming Regulations Covers all “Tobacco Products” [FDA Law Blog]

5. Traitements

Residual Disease in Oncogene-Driven Solid Tumours [ESMO]

5.12.3 Immunothérapies-combinaisons

Pfizer to trial triple-threat cancer cocktail therapy [FierceBiotech]

5.2.1 Pharma - Partenariats

What makes tumours tick? Genomics pave the way for tailored treatments [The Guardian]

5.2.3 Pharma - économie

Mutual Fund Industry to Drugmakers: Stand Up and Defend Yourself [Bloomberg]

5.3 Traitements - FDA, EMA,...

Public wary of faster approvals of new drugs, STAT-Harvard poll finds [STAT]

5.3.4 Traitements - AMM (FDA, EMA)

FDA expands Imbruvica's label to include survival data [Pharma Times]

6. Lutte contre les cancers

NIH plans overhaul of clinical center leadership [Science]

Staff at Baidu cancer death scandal hospital in China disciplined: China Daily [Reuters]

6.1 Observation

Breast cancer patients who lack knowledge about their own tumor are less likely to receive recommended treatment, study finds [Dana-Farber Cancer Institute]

6.10 Politiques

US senator introduces a ‘Right to Try’ bill for desperate patients [STAT]

After the elections, how are the devolved nations planning to tackle cancer? [Cancer Research UK]

6.7 DMP, Big Data & applis

Big Data’s Big Implications for Cancer Treatments [GEN]

6.8 Communication

John Oliver teaches us how to interpret medical and scientific studies [Respectful Insolence]

6.9 Controverses

Big drug maker presses for money-back guarantee that its science will work [STAT]

The Imprinter of All Maladies [it is NOT junk]